GDF15-GFRAL signaling drives weight loss and lipid metabolism in mouse model of amyotrophic lateral sclerosis DOI Creative Commons
Germana Cocozza,

Ludovica Maria Busdraghi,

Giuseppina Chece

et al.

Brain Behavior and Immunity, Journal Year: 2024, Volume and Issue: 124, P. 280 - 293

Published: Dec. 11, 2024

Weight loss is a common early sign in amyotrophic lateral sclerosis (ALS) patients and negatively correlates with survival. In different cancers metabolic disorders, high levels of serum growth differentiation factor 15 (GDF15) contribute to decrease food intake body weight, acting through GDNF family receptor alpha-like (GFRAL). Here we report that GDF15 highly expressed the peripheral blood ALS hSOD1

Language: Английский

Growth differentiation factor 15: Emerging role in liver diseases DOI
Yu Li, Jie Zhang, Shurong Chen

et al.

Cytokine, Journal Year: 2024, Volume and Issue: 182, P. 156727 - 156727

Published: Aug. 6, 2024

Language: Английский

Citations

5

Repression of oxidative phosphorylation by NR2F2, MTERF3 and GDF15 in human skin under high-glucose stress DOI Creative Commons

Seyta Ley‐Ngardigal,

Stéphane Claverol,

Lauren Sobilo

et al.

Redox Biology, Journal Year: 2025, Volume and Issue: unknown, P. 103613 - 103613

Published: March 1, 2025

Lifestyle factors such as a Western diet or metabolic diseases like diabetes disrupt glucose homeostasis and induce stress responses, yet their impact on skin metabolism structural integrity remains poorly understood. Here, we performed multiomic bioenergetic analyses of human dermal fibroblasts (HDFs), equivalent dermis (HED), reconstructed (HRS), explants from diabetic patients. We found that 12 mM represses oxidative phosphorylation (OXPHOS) through dual mechanism: the glucose-dependent nuclear receptor NR2F2 activates mitochondrial transcription termination factor 3 (MTERF3) while inhibiting growth-differentiation 15 (GDF15). Promoter assays revealed MTERF3 is regulated by MYCN, whereas GDF15 modulated FOS. Consequently, OXPHOS proteins respiration were suppressed, overexpression additionally interfered with collagen biosynthesis. In contrast, supplementation fully rescued hyperglycemia-induced metabolomic alterations, suggesting pharmacological strategy to mitigate hyperglycemic damage in skin. Finally, silencing TFAM impaired fibroblast haptotaxis reconstruction, underscoring crucial role energetics structure function. Collectively, these findings identify NR2F2-MTERF3-GDF15 axis key mediator suppression highlight potential therapeutic target preserve under stress.

Language: Английский

Citations

0

The role of the hypothalamus in the development of cancer cachexia DOI

Dimitrios Stagikas,

Yannis V. Simos, Λάμπρος Λάκκας

et al.

Physiology & Behavior, Journal Year: 2025, Volume and Issue: unknown, P. 114909 - 114909

Published: April 1, 2025

Language: Английский

Citations

0

GDF15, an Emerging Player in Renal Physiology and Pathophysiology DOI Open Access
Samia Lasaad, Gilles Crambert

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(11), P. 5956 - 5956

Published: May 29, 2024

These last years, the growth factor GDF15 has emerged as a key element in many different biological processes. It been established being produced response to pathological states and is now referred stress-related hormone. Regarding kidney functions, involved pathologies such chronic disease, diabetic nephropathy, renal cancer, so on. Interestingly, recent studies also revealed role of homeostatic mechanisms allowing maintain constant, far possible, plasma parameters pH K

Language: Английский

Citations

3

Macrophages as a Source and Target of GDF-15 DOI Open Access

Lina Silva-Bermudez,

Harald Klüter, Julia Kzhyshkowska

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(13), P. 7313 - 7313

Published: July 3, 2024

Growth differentiation factor 15 (GDF-15) is a multifunctional cytokine that belongs to the transforming growth factor-beta (TGF-β) superfamily. GDF-15 involved in immune tolerance and elevated several acute chronic stress conditions, often correlating with disease severity patient prognosis cancer172 metabolic cardiovascular disorders. Despite these clinical associations, molecular mechanisms orchestrating its effects remain be elucidated. The of are pleiotropic but cell-specific dependent on microenvironment. While expression can stimulated by inflammatory mediators, predominant were reported as anti-inflammatory pro-fibrotic. role macrophage system has been increasingly investigated recent years. Macrophages produce high levels during oxidative lysosomal stress, which lead fibrogenesis angiogenesis at tissue level. At same time, macrophages respond switching their phenotype tolerogenic one. Several GDF-15-based therapies under development, including analogs/mimetics GDF-15-targeting monoclonal antibodies. In this review, we summarize major physiological pathological contexts interacts macrophages. We also discuss challenges future perspectives therapeutic translation GDF-15.

Language: Английский

Citations

3

Hepatocyte-specific GDF15 overexpression improves high-fat diet-induced obesity and hepatic steatosis in mice via hepatic FGF21 induction DOI Creative Commons

Kento Takeuchi,

Kanji Yamaguchi, Yusuke Takahashi

et al.

Scientific Reports, Journal Year: 2024, Volume and Issue: 14(1)

Published: Oct. 14, 2024

GDF15 and FGF21, stress-responsive cytokines primarily secreted from the liver, are promising therapeutic targets for metabolic dysfunction-associated steatotic liver disease (MASLD). However, interaction between FGF21 remains unclear. We examined effects of hepatocyte-specific or overexpression in high-fat diet (HFD)-fed mice 8 weeks. Hydrodynamic injection sustained high circulating levels respectively, resulting marked reductions body weight, epididymal fat mass, insulin resistance, hepatic steatosis. In addition, treatment led to early reduction weight despite no change food intake, indicating role other than appetite loss. increased liver-derived serum levels, whereas did not affect expression. promoted eIF2α phosphorylation XBP1 splicing, leading induction. murine AML12 hepatocytes treated with free fatty acids (FFAs), upregulated Fgf21 mRNA splicing. Overall, continuous exposure excess FFAs resulted a gradual increase β-oxidation-derived reactive oxygen species endoplasmic reticulum stress, suggesting that enhanced this pathway induced GDF15- FGF21-related crosstalk is an important MASLD.

Language: Английский

Citations

3

Growth and differentiation factor 15: An emerging therapeutic target for brain diseases DOI Open Access

Yingying Zhou,

Lei Dou, Luyao Wang

et al.

BioScience Trends, Journal Year: 2025, Volume and Issue: 19(1), P. 72 - 86

Published: Jan. 24, 2025

Growth and differentiation factor 15 (GDF15), a member of the transforming growth factor-βsuperfamily, is considered stress response has garnered increasing attention in recent years due to its roles neurological diseases. Although many studies have suggested that GDF15 expression elevated patients with neurodegenerative diseases (NDDs), glioma, ischemic stroke, effects increased potential underlying mechanisms remain unclear. Notably, experimental shown multidimensional beneficial on NDDs, overexpression able rescue NDD-associated pathological changes phenotypes. In exerts opposite effects, it both protumorigenic antitumorigenic. The causes these conflicting findings are not comprehensively clear, but inhibiting helpful for suppressing tumor progression. also regarded as biomarker poor clinical outcomes stroke patients, targeting may help prevent this disease. Thus, we systematically reviewed synthesis, transcriptional regulation, biological functions related signaling pathways within brain. Furthermore, explored therapeutic target assessed applicability interventions brain By integrating latest research findings, study provides new insights into future treatment

Language: Английский

Citations

0

GDF15 is still a mystery hormone DOI
Casper M. Sigvardsen, Michael M. Richter, Sarah Engelbeen

et al.

Trends in Endocrinology and Metabolism, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 1, 2024

Language: Английский

Citations

2

Body Image, Nutrition, and Mental Health DOI Open Access
Hubertus Himmerich,

Khadijeh Mirzaei

Nutrients, Journal Year: 2024, Volume and Issue: 16(8), P. 1106 - 1106

Published: April 10, 2024

Classical examples of disorders associated with body image disturbances are eating (EDs) such as anorexia nervosa (AN) and bulimia (BN), well dysmorphic disorder (BDD) [...]

Language: Английский

Citations

1

Growth Differentiation Factor 15 during pregnancy and postpartum as captured in blood, cerebrospinal fluid and placenta: a cohort study on associations with maternal mental health DOI Creative Commons

Stinne Høgh,

Camilla Borgsted, Hanne Kristine Hegaard

et al.

Psychoneuroendocrinology, Journal Year: 2024, Volume and Issue: 171, P. 107212 - 107212

Published: Oct. 11, 2024

Language: Английский

Citations

1